Illumina completed the acquisition of IDbyDNA.

Illumina, a global company that develops innovative array-based solutions for DNA, RNA, and protein analysis, completed the acquisition of IDbyDNA, a company developing metagenomic technology for infectious disease testing and pathogen surveillance. Financial terms were not disclosed. The firms have had an alliance for the past two years comarketing IDbyDNA's Explify platform for use with Illumina's NGS instruments and library preparation kits. They also were codeveloping research-use-only workflows.